Wells Fargo Downgrades Pharmasset (VRUS) to Market Perform; To Be Acquired By GILD
Go back to Wells Fargo Downgrades Pharmasset (VRUS) to Market Perform; To Be Acquired By GILD| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.44 +4.52 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.92 | 52 Week High | $108.63 | |||
| Open | $140.00 | 52 Week Low | $71.39 | |||
| Day High | $143.89 | P/E | 79.25 | |||
| Day Low | $139.54 | EPS | $1.81 | |||
| Volume | 5,756,370 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
